Fulcrum Therapeutics
FULC
FULC
117 hedge funds and large institutions have $148M invested in Fulcrum Therapeutics in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 31 increasing their positions, 43 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
117
Holders Change
-2
Holders Change %
-1.68%
% of All Funds
1.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
31
Reduced
43
Closed
19
Calls
$148K
Puts
$40K
Net Calls
+$108K
Net Calls Change
-$5.12M
Top Buyers
| 1 |
SCM
Suvretta Capital Management
New York
|
+$4.98M |
| 2 |
EAM
Exome Asset Management
New York
|
+$1.17M |
| 3 |
Renaissance Technologies
New York
|
+$1.16M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$887K |
| 5 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$848K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$3.59M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$1.48M |
| 3 |
BlackRock
New York
|
-$1.32M |
| 4 |
PA
Perceptive Advisors
New York
|
-$1.12M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$809K |
